Table 2 Primers for TP53 exon 2–11 amplification and sequencing analysis
From: Prognostic role of serum p53 antibodies in lung cancer
| TP53 exon 2 | Fw | 5′ GGTTGGAAGTGTCTCATGC 3′ |
| Rv | 5′ TTCGCTTCCCACAGGTCTC 3′* | |
| TP53 exon 3 | Fw | 5′ AGAGACCTGTGGGAAGCGA 3′* |
| Rv | 5′ GCAGTCAGAGGACCAGGT 3′ | |
| TP53 exon 4a | Fw | 5′ TGGTCCTCTGACTGCTCTT 3′ |
| Rv | 5′ AAGAAGCCCAGACGGAAACC 3′* | |
| TP53 exon 4b | Fw | 5′ AGCTCCCAGAATGCCAGAG 3′* |
| Rv | 5′ CAGGCATTGAAGTCTCATGG 3′ | |
| TP53 exon 5 | Fw | 5′GCCCTGACTTTCAACTCTG 3′ |
| Rv | 5′ GGCAACCAGCCCTGTCGT 3′* | |
| TP53 exon 6 | Fw | 5′ CAGGCCTCTGATTCCTCAC 3′ |
| Rv | 5′ CTACTGCTCACCTGGAGG 3′* | |
| TP53 exon 7 | Fw | 5′ CTTGGGCCTGTGTTATCTC 3′ |
| Rv | 5′AAATCGGTAAGAGGTGGGC 3′* | |
| TP53 exon 8 | Fw | 5′ ACAAGGGTGGTTGGGAGTAG 3′* |
| Rv | 5′ CCTCCACCGCTTCTTGTCC 3′ | |
| TP53 exon 9 | Fw | 5′CAAGAAGCGGTGGAGGAGA 3′* |
| Rv | 5′ TCCACTTGATAAGAGGTCCCA 3′ | |
| TP53 exon 10 | Fw | 5′ CCATCTTTTAACTCAGGTACTG 3′ |
| Rv | 5′TGAAGGCAGGATGAGAATGG 3′* | |
| TP53 exon 11 | Fw | 5′CACAGACCCTCTCACTCAT 3′ |
| Rv | 5′TCCTGGGTGCTTCTGACG 3′* |